1564-P: Hepatic Lipid Content Associates with Fasting and Prandial Glucagon Secretion in Recent-Onset Type 2 Diabetes
Maximilian Huttasch(Deutsches Diabetes-Zentrum e.V.), for the GDS Group(Hochschule Düsseldorf University of Applied Sciences), Tim Mori, VERA SCHRAUWEN-HINDERLING, Nicolai J. Wewer Albrechtsen(University of Copenhagen), Nina Trinks(Deutsches Diabetes-Zentrum e.V.), SABINE KAHL(Hochschule Düsseldorf University of Applied Sciences), Geronimo Heilmann(University of Duisburg-Essen), Martin Schön(Deutsches Diabetes-Zentrum e.V.), Volker Burkart(Deutsches Diabetes-Zentrum e.V.), SANDRA TRENKAMP, Yuliya Kupriyanova(Deutsches Diabetes-Zentrum e.V.), Róbert Wágner(Deutsches Diabetes-Zentrum e.V.), Anna Giannakogeorgou(Hochschule Düsseldorf University of Applied Sciences), Michael Roden(Düsseldorf University Hospital)
Cited by 0
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
The integrative biology of type 2 diabetes
|Nature|2019|1.1k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789